Atomistry » Zinc » PDB 3lju-3lt9 » 3lka
Atomistry »
  Zinc »
    PDB 3lju-3lt9 »
      3lka »

Zinc in PDB 3lka: Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide

Enzymatic activity of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide

All present enzymatic activity of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide:
3.4.24.65;

Protein crystallography data

The structure of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide, PDB code: 3lka was solved by V.Calderone, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 36.91 / 1.80
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 51.566, 60.194, 54.215, 90.00, 115.09, 90.00
R / Rfree (%) 16.9 / 21

Other elements in 3lka:

The structure of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide also contains other interesting chemical elements:

Calcium (Ca) 3 atoms

Zinc Binding Sites:

The binding sites of Zinc atom in the Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide (pdb code 3lka). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide, PDB code: 3lka:
Jump to Zinc binding site number: 1; 2;

Zinc binding site 1 out of 2 in 3lka

Go back to Zinc Binding Sites List in 3lka
Zinc binding site 1 out of 2 in the Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn264

b:9.0
occ:1.00
NE2 A:HIS228 2.1 8.0 1.0
NE2 A:HIS222 2.1 3.9 1.0
NE2 A:HIS218 2.1 3.7 1.0
O A:HAE269 2.2 19.5 1.0
O2 A:HAE269 2.3 21.2 1.0
O A:HOH305 2.8 16.3 0.4
CD2 A:HIS218 3.0 2.8 1.0
CE1 A:HIS228 3.0 9.5 1.0
CD2 A:HIS222 3.0 3.2 1.0
C2 A:HAE269 3.1 22.1 1.0
N A:HAE269 3.1 18.8 1.0
CD2 A:HIS228 3.1 8.7 1.0
CE1 A:HIS222 3.2 3.5 1.0
CE1 A:HIS218 3.2 5.1 1.0
O A:HOH10 4.1 4.0 1.0
ND1 A:HIS228 4.1 7.9 1.0
N1 A:M4S1 4.1 19.9 1.0
OE1 A:GLU219 4.2 2.8 1.0
CG A:HIS218 4.2 5.1 1.0
CG A:HIS228 4.2 9.2 1.0
CG A:HIS222 4.2 5.0 1.0
ND1 A:HIS222 4.3 4.0 1.0
ND1 A:HIS218 4.3 7.1 1.0
O A:HOH97 4.4 18.5 1.0
C1 A:HAE269 4.6 21.5 1.0
OE2 A:GLU219 4.7 4.5 1.0
CD A:GLU219 4.9 3.8 1.0
CE A:MET236 4.9 7.8 1.0

Zinc binding site 2 out of 2 in 3lka

Go back to Zinc Binding Sites List in 3lka
Zinc binding site 2 out of 2 in the Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of Catalytic Domain of Human Mmp-12 Complexed with Hydroxamic Acid and Paramethoxy-Sulfonyl Amide within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Zn265

b:11.7
occ:1.00
OD1 A:ASP170 1.9 8.2 0.7
CE1 A:HIS183 2.0 10.8 1.0
NE2 A:HIS168 2.1 7.6 1.0
ND1 A:HIS196 2.2 6.0 1.0
NE2 A:HIS183 2.7 15.6 1.0
CG A:ASP170 2.9 11.7 0.7
CD2 A:HIS168 3.0 8.3 1.0
CE1 A:HIS168 3.1 8.4 1.0
ND1 A:HIS183 3.1 14.0 1.0
OD2 A:ASP170 3.2 9.6 0.7
CG A:HIS196 3.2 6.9 1.0
CE1 A:HIS196 3.2 7.5 1.0
CB A:HIS196 3.4 5.8 1.0
CD2 A:HIS183 4.0 13.0 1.0
CG A:HIS168 4.1 9.8 1.0
ND1 A:HIS168 4.1 9.3 1.0
CG A:HIS183 4.2 8.8 1.0
O A:HIS172 4.2 16.9 1.0
CB A:ASP170 4.2 14.5 0.7
NE2 A:HIS196 4.3 8.7 1.0
CD2 A:HIS196 4.3 6.2 1.0
CE2 A:PHE185 4.5 14.2 1.0
CB A:HIS172 4.5 18.3 1.0
CZ A:PHE185 4.6 14.5 1.0
CZ A:PHE174 4.7 6.8 1.0
CE1 A:PHE174 4.8 7.3 1.0
C A:HIS172 4.9 16.5 1.0
CA A:HIS196 5.0 6.0 1.0

Reference:

V.Borsi, V.Calderone, M.Fragai, C.Luchinat, N.Sarti. Entropic Contribution to the Linking Coefficient in Fragment Based Drug Design: A Case Study. J.Med.Chem. V. 53 4285 2010.
ISSN: ISSN 0022-2623
PubMed: 20415416
DOI: 10.1021/JM901723Z
Page generated: Sat Oct 26 08:41:04 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy